multivessel

PCI with everolimus eluting stent or CABG for multivessel coronary artery disease.

Original title:&nbsp;Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease.&nbsp;Reference:&nbsp;Sripal Bangalore, M.D. et al. N Engl J Med. 2015 Mar 26;372(13):1213-22. Coronary artery bypass grafting (CABG) have had better outcomes than percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease. &nbsp;However, this information comes from studies that do not include new generation stents.<a href="https://solaci.org/en/2015/04/09/pci-with-everolimus-eluting-stent-or-cabg-for-multivessel-coronary-artery-disease/" title="Read more" >...</a>

Is the 2nd generation DES an alternative to surgery in multivessel coronary disease?

The benefits of 2nd generation drug-eluting stents (DES) are being compared with Coronary artery bypass graft surgery (CABG), looking to achieve a safe, effective, less invasive and as complete as possible revascularization. As background of SYNTAX, the stent thrombosis (ST) with Taxus, reached 25% of the events in the group of intervention (PCI), so that<a href="https://solaci.org/en/2015/04/07/is-the-2nd-generation-des-an-alternative-to-surgery-in-multivessel-coronary-disease/" title="Read more" >...</a>

Multivessel angioplasty in acute myocardial infarction improves prognosis

Original title:&nbsp;Acute multivessel revascularization improves 1 year outcomes in ST-elevation myocardial infarction. A nationwide study from AMIS plus registry.&nbsp;Reference:&nbsp;Raban Jeger, et al. International journal of Cardiology 2014;172:76-81 &nbsp; The presence of multiple vessel lesions is present in about 50% of patients referred for primary angioplasty. The accepted strategy is to treat the culprit artery even<a href="https://solaci.org/en/2014/03/07/multivessel-angioplasty-in-acute-myocardial-infarction-improves-prognosis/" title="Read more" >...</a>

Difference in mortality with surgery versus angioplasty in diabetic multivessel patients

Original title:&nbsp;Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: A meta-analysis of randomized controlled trials.&nbsp;Reference:&nbsp;Verma S. et al.&nbsp;Lancet Diabetes Endocrinol. 2013;Epub ahead of print. The FREEDOM study was the last of the randomized studies that compared the results of surgery versus coronary angioplasty in diabetic multivessel patients showing a<a href="https://solaci.org/en/2013/09/18/difference-in-mortality-with-surgery-versus-angioplasty-in-diabetic-multivessel-patients/" title="Read more" >...</a>

Diabetics with multivessel, must keep waiting.

Original title:&nbsp;Strategies for Multivessel Revascularization in Patients with Diabetes. The FREEDOM Trial.&nbsp;Reference:&nbsp;Michael E. Farkouh et al. N Engl J Med 2012. DOI: 10.1056/NEJMoa1211585 This study was designed to determine the best revascularization strategy in diabetic patients with multivessel using current techniques of angioplasty (PCI) and surgery (CABG). Randomized 1:1 diabetic patients with injuries &gt; 70%<a href="https://solaci.org/en/2012/11/08/diabetics-with-multivessel-must-keep-waiting/" title="Read more" >...</a>

Global Risk Score for stratification of patients with multivessel coronary artery disease: A wider look

Reference: Serruys et al J Am Coll Cardiol Intv 2012;5:606&ndash;17 SYNTAX Analysis study demonstrates the utility of a new risk score for patients stratification with left main coronary artery or multivessel disease. Numerous studies have demonstrated the value of SYNTAX score to stratify risk of angioplasty and decision-making (angioplasty versus surgery) in patients with multivessel<a href="https://solaci.org/en/2012/10/01/global-risk-score-for-stratification-of-patients-with-multivessel-coronary-artery-disease-a-wider-look/" title="Read more" >...</a>

Incomplete Revascularization Linked With Mortality in Multivessel Disease Patients

Reference:&nbsp;Wu C, Dyer AM, Kinas SB, et al. Impact of incomplete revascularization on long-term mortality after coronary stenting. Circ Cardiovasc Interv 2011; 4: 413-21. Complete revascularization was defined as a reduction of stenosis to less than 50% in all diseased (&ge; 70% stenosis) lesions in major epicardial coronary vessels at the initial hospitalization or within<a href="https://solaci.org/en/2011/11/29/incomplete-revascularization-linked-with-mortality-in-multivessel-disease-patients/" title="Read more" >...</a>

Una nueva molécula para evitar la nefropatía por contraste

Selecting Renal Denervation Responsive Patients: Meta-Analysis of Observational Data

Hypertension treatment has evolved considerably over time. However, managing adverse events driven by medication is still challenging, as is low patient adherence, be it because of polimedication or associated costs.&nbsp; Approximately 10% of patients do not reach optimal blood pressure targets, despite adherence optimal medical treatment (OMT); this condition is known as resistant hypertension.&nbsp; Renal<a href="https://solaci.org/en/2024/07/19/selecting-renal-denervation-responsive-patients-meta-analysis-of-observational-data/" title="Read more" >...</a>

Top